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ABSTRACT: The patient-centered medical home has emerged as a promising solution 
to address the significant fragmentation, poor quality, and high costs that afflict the U.S. 
health care system. The medical home model includes core components of primary and 
patient-centered care, recent innovations in practice redesign and health information tech-
nology, and changes to the way practices and providers are paid. There are initiatives 
across the country testing the promise of the medical home model. However, to properly 
evaluate and compare results that will aid in the implementation of these and other initia-
tives, researchers need a standard set of core measures. This brief describes the process 
and recommendations of more than 75 researchers who came together to identify a core set 
of standardized measures to evaluate the patient-centered medical home. It focuses on two 
domains of medical home outcomes: cost/utilization and clinical quality. 
            
INTRODUCTION
Strong primary care is critical to a well-functioning health care system.1  
Nonetheless, primary care in the United States is widely viewed as in dire need 
of improvement. The patient-centered medical home (PCMH) has emerged as a 
promising solution to address the significant fragmentation, poor quality, and high 
costs that afflict our system. The medical home model includes core components 
of primary and patient-centered care, recent innovations in practice redesign and 
health information technology, and changes to the way practices and providers  
are paid.2
There are numerous initiatives across the country testing the promise of 
the medical home model. More than 90 commercial health plans, 42 states, and 
three federal initiatives are participating in such tests, with thousands of providers 
who serve millions of patients.3 However, only a few evaluations have published 
on the impact of the PCMH model as a whole, although elements have been 
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shown to be associated with higher quality and lower 
cost.4 Rigorous evaluations and standardization of key 
outcomes are needed to strengthen the empirical basis 
for the medical home concept, as well as to assess the 
viability of implementation. With rigorous, comparable 
data, payers, providers, and patients will be better 
positioned to understand results, improve the model, 
strengthen primary care, achieve high performance, 
and experience better health outcomes.
This brief describes the process and recom-
mendations of more than 75 researchers who came 
together to identify a core set of standardized measures 
to evaluate the patient-centered medical home. The 
summary focuses on two domains of medical home 
outcomes: cost/utilization and clinical quality. 
THE PCMH EVALUATORS’ COLLABORATIVE
The Commonwealth Fund established the Patient-
Centered Medical Home Evaluators’ Collaborative 
in 2009 to align evaluation methods, share best prac-
tices, and exchange information to improve evalua-
tion designs. The collaborative comprises more than 
75 researchers (see Appendix A1) who are engaged in 
evaluating PCMH demonstrations.
The objectives of the PCMH Evaluators’ 
Collaborative are to:
l reach consensus on a standard core set of out-
come measures and instruments;
l share the consensus on instruments, metrics, 
and methodological lessons with interested 
researchers around the country; and
l foster an ongoing and supportive exchange that 
helps evaluators share ideas that improve their 
evaluation designs, analytic approach, and 
interpretation of findings.
Between 2009 and 2011, the PCMH 
Evaluators’ Collaborative organized five work groups 
to reach consensus on a common set of measures to 
evaluate medical home initiatives. The work groups 
each focused on a key dimension of PCMH evalu-
ation: cost and utilization, clinical quality, patient 
experience, clinician and staff experience, and process 
and implementation. Each work group reviewed the 
literature, developed logic models, and met regularly 
to debate effective and feasible measures to evaluate 
medical home pilots in each dimension. The cost and 
utilization work group published its results online in 
Medical Care Research and Review in June 2010.5 In 
January 2011, the implementation group published 
a paper in Medical Care that outlined seven recom-
mendations for medical home evaluators to consider 
in future studies.6 The clinical quality group presented 
its findings at national meetings.7 The findings of 
the clinician and staff experience group are being 
prepared for submission to a peer-reviewed journal. 
Finally, the work of the patient experience commit-
tee was incorporated into work by a team of Harvard, 
Yale, and National Committee for Quality Assurance 
(NCQA) researchers to develop and test the new 
PCMH–Consumer Assessment of Healthcare Providers 
and Systems (CAHPS) survey, which was released by 
the Agency for Healthcare Research and Quality in 
January 2012.8
The potential of the medical home to increase 
efficiency and lower costs of care while simultaneously 
improving quality are the primary reasons most payers 
and policymakers have thrown their support behind 
PCMH. Given the salience of the cost and quality out-
comes in ongoing and future discussions about health 
care reform, members of The Commonwealth Fund 
PCMH Evaluators’ Collaborative met in June 2011 to 
discuss the recommendations of the cost/utilization 
and clinical quality work groups with the goal of iden-
tifying a minimum set of measures that would enable 
meaningful cross-study comparison. With a core, stan-
dardized set of measures in these two key domains, the 
evaluators could increase the comparability and there-
fore the usefulness of the forthcoming body of research 
for policymaking. A survey of collaborative members 
was conducted to ascertain support for including spe-
cific measures and measurement principles in this core 
set to establish a common ground for assessment. In 
this report, we summarize the recommendations from 
this group of evaluators as guideposts for medical 
home evaluations.
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RECOMMENDED UTILIZATION AND COST 
MEASURES FOR PCMH EVALUATION
The vast majority of participants supported the recom-
mendations of the cost and utilization work group to 
include emergency department (ED) visits, hospital-
izations, and readmissions as the primary utilization 
indicators in the minimum measure set (Table 1). 
According to the work group’s analysis, these indica-
tors were both consistent with the logic model that 
attempted to capture all the levers a medical home 
could use to affect utilization, cost, and efficiency and 
were supported by at least some empirical evidence.
For cost measures, there was consensus that 
evaluations should always include analysis of total per 
member per month cost effects for high-risk patients, 
since the PCMH initiative will most likely be able to 
detect a measureable effect on this patient population. 
A new measure on total cost of care and resource use, 
which was endorsed by the National Quality Forum 
in January 2012, was not yet available for consider-
ation during deliberations in June 2011, though it does 
appear to be promising.9
We asked evaluators to delve further into cost 
and utilization measurement. We asked them:
1. Should evaluators look at ambulatory care–
sensitive (ACS) measures of hospitalization 
and emergency department use, all use, or both?
2. Should evaluators always use risk adjustment 
and if so, should a specific, common approach 
be used to adjust cost and utilization data for 
patient risk factors?
3. For cost measures, should evaluators use stan-
dardized pricing (that is, use a common fee 
schedule to re-price services so that fee differ-
ences between payers or providers do not drive 
results)? If so, should a single standard (e.g., 
Medicare, for a specific geography, etc.) be 
proposed?
On these technical questions, there was greater 
diversity and uncertainty among respondents. A sub-
stantial majority of respondents supported the report-
ing of both ACS and all admissions and ED visits, 
although a significant minority opted for flexibility, 
perhaps based on initiative-specific considerations—
for example, population size and characteristics, focus 
of medical home quality improvement efforts, etc. 
Nearly everyone agreed that risk adjustment should be 
required, but only a minority thought there should be 
a common method. Fewer evaluators supported cost 
standardization but comments clearly indicated legiti-
mate confusion about what this would mean and how 
feasible such standardization would be.
In our judgment, these technical questions are 
important considerations that will be influenced by 
local constraints and other factors. For example, risk 
adjustment is clearly needed to make any assessment 
of cost and utilization interpretable by decision-makers  
but the method of doing so may vary because of software  
availability or population characteristics. Evaluators 
can make their results more broadly useful by using 
standard, validated algorithms and by making trans-
parent exactly how utilization measures were defined, 
how costs were calculated, and by what method these 
measures were adjusted for patient risk factors.
RECOMMENDED CLINICAL QUALITY 
MEASURES FOR PCMH EVALUATION
Among the PCMH Evaluators’ Collaborative partici-
pants, there was broad agreement about the importance 
of assessing changes in clinical quality as part of any 
medical home program. The evaluators expressed con-
cerns that the variation in populations and local PCMH 
emphasis might make uniform minimum quality mea-
sure sets difficult to generalize. Therefore, the group 
Table 1. Core Cost and Utilization Measures  
for Cross-Study Comparison of PCMHs
Utilization
Emergency department visits, ambulatory care–sensitive (ACS) and all
Acute inpatient admissions, ACS and all
Readmissions within 30 days
Cost
Total per member per month costs
Total per member per month costs for high-risk patients
Technical issues: all utilization and cost issues should be risk-adjusted; 
method of pricing should be transparent and standardized if possible
Source: Commonwealth Fund Patient-Centered Medical Home Evaluators’ Collaborative.
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agreed to a core set of principles that all evaluators 
should follow when evaluating clinical quality (Table 
2). In particular, the evaluators agreed that researchers 
should select measures from each of the following core 
areas of primary care measurement: preventive care, 
chronic disease management, acute care, overuse,  
and safety.
The clinical quality work group assembled a 
proposed set of standardized, validated technical qual-
ity measures relevant to the patient-centered medical 
home concept. These included existing Ambulatory 
Care Quality Alliance (AQA) recommendations as well 
as the Healthcare Effectiveness Data and Information 
Set (HEDIS) measure set, the Physician Quality 
Reporting Initiative (PQRI) measures, and other state 
and payer demonstration measures. After a lengthy 
process discussing measure attributes, advantages, dis-
advantages, and use across the country, the work group 
engaged in a modified Delphi process to come up with 
a consensus set of metrics. These measures are listed 
below in Table 3. Supplemental adult measures and 
core pediatric measures for PCMH evaluation are listed 
in Appendix A2 and Appendix A3. Patient experience 
measures are adequately covered in the new medical 
home CG-CAHPS tool, which the work group believes 
is a good starting point for validated measurement in 
this domain.10 To a large degree, these recommended 
technical quality and patient experience measures over-
lap with recently released accountable care organiza-
tion (ACO) final rule quality measures.
Two measurement issues were underscored. To 
be interpretable, researchers should apply a validated 
approach to data collection. This is particularly impor-
tant if measures are collected from the medical record 
or electronic health record (EHR). In addition, evalu-
ators should use consistent measures across practices 
within a pilot or demonstration.
A further consideration in PCMH quality  
measurement consists of finding the appropriate mix of 
process and outcome measures. On one hand, given  
the focus on managing the health of a defined popula-
tion, intermediate outcome measures—often of chronic 
disease—might be preferred over process measures. To 
meet this need, the work group selected a number of 
validated diabetes and cardiovascular outcome mea-
sures. However, given concerns about the ability of 
PCMH pilots to demonstrate large outcome changes 
over short time periods, the work group also empha-
sized key process measures as well. These measures 
might be more readily affected over a short time 
period, and they also have the advantage of often  
having lower variance, which allows for detection of 
statistically significant changes in a smaller sample  
of practices.
In addition to basic quality principles, certain 
quality measures should be used for meta-analysis. The 
recommended measures for meta-analysis are listed in 
Table 4 below. 
Table 2. Principles and Measures for Assessing  
Clinical Quality in PCMHs
Evaluators should use standardized, validated, nationally endorsed 
measures. The PCMH Evaluators’ Collaborative clinical quality work group 
recommends selecting a group of quality measures from the lists in  
Appendix A2 and Appendix A3. We recommend the measures listed in 
Table 3 as a core set.
Evaluators should select measures from each of the following areas of 
primary care: preventive care, chronic disease management, acute care, 
overuse, and safety.
Evaluators should apply a validated approach to data collection. This 
is particularly important if pulling measures from the medical record or 
electronic health record.
Evaluators should use consistent measures across practices within  
a demonstration.
Source: Commonwealth Fund Patient-Centered Medical Home Evaluators’ Collaborative.
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Table 3. Core Recommended Adult Technical Quality Measures for PCMHs
Measure Description Data Source(s) Composite Domain Measure Source
Avoidance of anti-
biotic treatment in 
adults with acute 
bronchitis (AAB)
Percentage of adults ages 18–64 with a diagnosis of acute  
bronchitis who were not dispensed an antibiotic prescription
Claims Effectiveness of Care: 
Respiratory Conditions
NCQA: HEDIS 2012 
Measure Set 
Adult weight 
screening and 
follow-up
Percentage of patients age 18 years and older with a calculated 
body mass index (BMI) in the past six months or during the cur-
rent visit documented in the medical record AND if the most 
recent BMI is outside the parameters, a follow up plan is docu-
mented. Normal parameters: 
Age 65 and older BMI ≥23 and <30 
Ages 18–64 BMI  ≥18.5 and <25
Claims 
EHR
Effectiveness of Care: 
Prevention and Screening
CMS/ 
NQF 0421
Medication 
Management for 
People with Asthma 
(MMA)
The percentage of members ages 18–64 during the measurement 
year who were identified as having persistent asthma and who 
were dispensed appropriate medications and remained on their  
medications during the treatment period. Two rates are reported: 
1. The percentage of members who remained on an asthma  
controller medication for at least 50% of the treatment period 
2. The percentage of members who remained on an asthma  
controller medication for at least 75% of the treatment period
Claims 
EHR
Effectiveness of Care: 
Respiratory Conditions
NCQA: HEDIS 2012 
Measure Set
Breast cancer 
screening (BCS)
Percentage of women ages 40–69 who had a mammogram to 
screen for breast cancer
Claims 
EHR
Effectiveness of Care: 
Prevention and Screening
NCQA: HEDIS 2012 
Measure Set
Cervical cancer 
screening (CCS)
Percentage of women ages 21–64 who received one or more  
Pap tests to screen for cervical cancer
Claims 
Medical record 
EHR
Effectiveness of Care: 
Prevention and Screening
NCQA: HEDIS 2012 
Measure Set
Chlamydia screen-
ing in women (CHL)
Percentage of women ages 16–24 who were identified as  
sexually active and who had at least one test for chlamydia  
during the measurement year
Claims 
EHR
Effectiveness of Care: 
Prevention and Screening
NCQA: HEDIS 2012 
Measure Set
Colorectal cancer 
Screening (COL)
Percentage of members ages 50–75 who had appropriate  
screening for colorectal cancer
Claims 
Medical record 
EHR
Effectiveness of Care: 
Prevention and Screening
NCQA: HEDIS 2012 
Measure Set
Cholesterol man-
agement for
patients with 
cardiovascular
conditions (CMC)
Percentage of members ages 18–75 who were discharged alive 
for acute myocardial infarction (AMI), coronary artery bypass 
graft (CABG), or percutaneous coronary interventions (PCI) from 
January 1 to November 1 of the year prior to the measurement 
year, or who had a diagnosis of ischemic vascular disease (IVD) 
during the measurement year and the year prior to the measure-
ment year, who had each of the following during the measurement 
year: 
LDL–C screening 
LDL–C control (<100 mg/dL)
Claims 
Medical record
Effectiveness of Care: 
Cardiovascular Conditions
NCQA: HEDIS 2012 
Measure Set
Antidepressant 
medication man-
agement (AMM)
Percentage of members age 18 and older who were diagnosed 
with a new episode of major depression and treated with antide-
pressant medication, and who remained on an antidepressant 
medication treatment. Two rates are reported: 
1. Effective acute phase treatment: the percentage of newly diag-
nosed and treated members who remained on an antidepressant 
medication for at least 84 days (12 weeks) 
2. Effective continuation phase treatment: the percentage of newly 
diagnosed and treated members who remained on an antidepres-
sant medication for at least 180 days (6 months)
Claims 
EHR
Effectiveness of Care: 
Behavioral Health
NCQA: HEDIS 2012 
Measure Set
Comprehensive 
diabetes care: 
Hemoglobin A1c 
(HbA1c) testing
Percentage of members ages 18–75 with diabetes (type 1 and 
type 2) who had HbA1c testing 
Claims 
Medical record 
EHR
Effectiveness of Care: 
Diabetes
NCQA: HEDIS 2012 
Measure Set
Comprehensive 
diabetes care: 
HbA1c poor control 
(>9.0%)
Percentage of members ages 18–75 with diabetes (type 1 and 
type 2) who had poor HbA1c control (>9.0%)
Claims 
Medical record 
EHR
Effectiveness of Care: 
Diabetes
NCQA: HEDIS 2012 
Measure Set
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Measure Description Data Source(s) Composite Domain Measure Source
Comprehensive dia-
betes care: blood 
pressure control 
(<140/80 mm Hg)
Percentage of members ages 18–75 with diabetes (type 1 and 
type 2) who had blood pressure control of <140/80 mm Hg 
Claims 
Medical record 
EHR
Effectiveness of Care: 
Diabetes
NCQA: HEDIS 2012 
Measure Set
Comprehensive 
diabetes care: 
Eye exam (retinal) 
performed
Percentage of members ages 18–75 with diabetes (type 1 and 
type 2) who had an eye exam (retinal) performed
Claims 
Medical record 
EHR
Effectiveness of Care: 
Diabetes
NCQA: HEDIS 2012 
Measure Set
Comprehensive  
diabetes care: 
LDL–C screening
Percentage of members ages 18–75 with diabetes (type 1 and 
type 2) who had an LDL–C screening
Claims 
Medical record 
EHR
Effectiveness of Care: 
Diabetes
NCQA: HEDIS 2012 
Measure Set
Comprehensive  
diabetes care: 
LDL–C <100 mg/dL
Percentage of members ages 18–75 with diabetes (type 1 and 
type 2) who had good LDL–C control (<100 mg/L)
Claims 
Medical record 
EHR
Effectiveness of Care: 
Diabetes
NCQA: HEDIS 2012 
Measure Set
Comprehensive 
diabetes care: 
Medical attention 
for nephropathy
Percentage of members ages 18–75 with diabetes (type 1 and 
type 2) who had medical attention for nephropathy
Claims 
Medical record 
EHR
Effectiveness of Care: 
Diabetes
NCQA: HEDIS 2012 
Measure Set
Comprehensive 
diabetes care
Percentage of members ages 18–75 with diabetes (type 1 and 
type 2) who had each of the following: hemoglobin A1c testing, 
HbA1c poor control (>9.0%), HbA1c control (<8.0%), HbA1c 
control (<7.0%) for a selected population, eye exam (retinal) per-
formed, LDL–C screening, LDL–C control (<100 mg/dL), medical 
attention for nephropathy, blood pressure control (<140/80 mm 
Hg), blood pressure control (<140/90 mm Hg)
Claims 
Medical record
Effectiveness of Care: 
Diabetes
NCQA: HEDIS 2012 
Measure Set
Controlling high 
blood pressure 
(CBP)
Percentage of members ages 18–85 who had a diagnosis of 
hypertension and whose blood pressure was adequately controlled 
(<140/90) during the measurement year
Claims 
Medical record
Effectiveness of Care: 
Cardiovascular Conditions
NCQA: HEDIS 2012 
Measure Set
Use of imaging 
studies for low back 
pain (LBP)
Percentage of members with a primary diagnosis of low back pain 
who did not have an imaging study (plain X-ray, MRI, CT scan) 
within 28 days of diagnosis
Claims 
EHR
Effectiveness of Care: 
Musculoskeletal Conditions
NCQA: HEDIS 2012 
Measure Set
Annual monitoring 
for patients on per-
sistent medications 
(MPM)
Percentage of members age 18 and older who received at least 
180 treatment days of ambulatory medication therapy for a select 
therapeutic agent during the measurement year and at least one 
therapeutic monitoring event for the therapeutic agent in the mea-
surement year. For each product line, report each of the four rates 
separately and as a total rate.
l annual monitoring for members of angiotensin converting 
enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB)
l annual monitoring for member on digoxin
l annual monitoring for members on diuretics
l annual monitoring for members on anticonvulsants
l total rate (the sum of the four numerators divided by the sum of 
the four denominators)
Claims Effectiveness of Care: 
Medication Management
NCQA: HEDIS 2012 
Measure Set
Pneumonia vac-
cination status for 
older adults (PNU)
Percentage of Medicare members age 65 and older as of January 
1 of the measurement year who have ever received a pneumococ-
cal vaccination
Survey 
EHR
Effectiveness of Care: 
Measures Collected Through 
the CAHPS Health Plan 
Survey
NCQA: HEDIS 2012 
Measure Set via the 
Medicare CAHPS 
Survey
Preventive Care 
and Screening 
Measure Pair: 
a) Tobacco Use 
Assessment, and b) 
Tobacco Cessation 
Intervention
a) Percentage of patients age 18 years and older who have been 
seen for at least 2 office visits who were queried about tobacco 
use one or more times within 24 months 
b) Percentage of patients age 18 years and older identified as 
tobacco users within the past 24 months and have been seen for 
at least 2 office visits, who received cessation intervention
Claims 
EHR
Effectiveness of Care: 
Prevention and Screening
CMS 
AMA—PCPI
Source: Commonwealth Fund Patient-Centered Medical Home Evaluators’ Collaborative.
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Table 4. Core Recommended Technical Quality Measures for PCMH Meta-Analysis
Adult Quality Measures
Claims-based measures Claims- and chart-based measures
Diabetes process measures All diabetes outcome measures
Pneumonia vaccination Tobacco assessment and intervention (aligned with Meaningful Use incentives and ACO models)
Cervical cancer screening BMI documentation and follow-up (aligned with Meaningful Use incentives and ACO models)
Breast cancer screening Hypertension control
Colorectal cancer screening Hyperlipidemia control
Antidepressant medication management Acute low back pain imaging
Overuse: antibiotics for acute bronchitis 
Safety: persistent medication monitoring
Asthma medication management (ages 18–64)
Child Quality Measures
Claims-based measures Claims- and chart-based measures
Well-child visits (all pre-specified ages) 2-year and 13-year immunizations
Appropriate testing for children with pharyngitis Body mass index assessment and follow-up percentile
Follow-up care for children prescribed attention deficit  
hyperactivity disorder medication
Asthma medication management (ages 5–18)
Source: Commonwealth Fund Patient-Centered Medical Home Evaluators’ Collaborative.
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Appendix A2. Supplemental Adult Technical Quality Measures for PCMH Evaluations
Measure Description
Data  
Source(s)
Important 
Considerations
Composite  
Domain
Measure  
Source
Fall risk manage-
ment (FRM)
The two components of this measure assess different facets of 
fall risk management: 
Discussing fall risk: the percentage of Medicare members 75 
and older or 65–74 with balance or walking problems or a fall in 
the past 12 months, who were seen by a practitioner in the past 
12 months and who discussed falls and problems with balance 
or walking with their current practitioner 
Managing fall risk: the percentage of Medicare members 65 and 
older who had a fall or had problems with balance or walking in 
the past 12 months, who were seen by a practitioner in the past 
12 months, and who received fall risk intervention from their  
current practitioner
Survey May require heavy 
chart abstraction
Effectiveness of 
Care: Measures 
Collected Through 
Medicare Health 
Outcome Survey
NCQA: HEDIS 
2012 Measure 
Set via the 
Medicare Health 
Outcomes Survey
Flu shots for adults 
ages 50–64 (FSA) 
and flu shots for 
older adults (FSO)
FSA: A rolling average represents the percentage of commercial 
members ages 50–64 who received an influenza vaccination 
between September 1 of the measurement year and the date 
when the CAHPS 4.0H Survey was completed
FSO: The percentage of Medicare members 65 and older as of 
January 1 of the measurement year who received an influenza 
vaccination between September 1 of the measurement year and 
the date when the Medicare CAHPS survey was completed
Survey May not be accurate 
due to wide variety 
of sources where 
patients could get an 
influenza vaccination
Effectiveness of 
Care: Measures 
Collected Through 
the CAHPS Health 
Plan Survey 
NCQA: HEDIS 
2012 Measure 
Set via CAHPS 
Health Plan 
Survey 4.0H, Adult 
Version (FSA) and 
Medicare CAHPS 
(FSO)
Medication rec-
onciliation post-
discharge (MRP)
The percentage of discharges from January 1–December 1 of the 
measurement year for members 66 and older for whom medica-
tions were reconciled on or within 30 days of discharge
Claims 
Medical record 
EHR
May be difficult to 
abstract from medical 
records
Effectiveness of 
Care: Medication 
Management
NCQA: HEDIS 
2012 Measure 
Set
Osteoporosis test-
ing in older women 
(OTO)
The percentage of Medicare women 65 years and over who 
report ever having received a bone density test to check for 
osteoporosis
Survey 
EHR
Some question the 
utility of this measure 
on a population basis
Effectiveness of 
Care: Measures 
Collected Through 
Medicare Health 
Outcome Survey
NCQA: HEDIS 
2012 Measure 
Set via the 
Medicare Health 
Outcome Survey
Medical assistance 
with smoking and 
tobacco use cessa-
tion (MSC)
The three components of this measure assess different facets  
of providing medical assistance with smoking and tobacco use 
cessation: 
Advising smokers and tobacco users to quit: a rolling average 
represents the percentage of members 18 and older who are 
current smokers or tobacco users and who received cessation 
advice during the measurement year 
Discussing cessation medications: a rolling average represents 
the percentage of members 18 and older who are current smok-
ers or tobacco users and who discussed or were recommended 
cessation medications during the measurement year 
Discussing cessation strategies: a rolling average represents the 
percentage of members 18 and older who are current smokers 
or tobacco users who discussed or were provided cessation 
methods or strategies during the measurement year
Survey 
EHR
May be more robust 
and linkable to 
outcomes than the 
smoking cessation 
advice measure; 
Documentation in the 
chart more likely to 
be inadequate
Effectiveness of 
Care: Measures 
Collected Through 
the CAHPS Health 
Plan Survey
NCQA: HEDIS 
2012 Measure 
Set; Collected via 
CAHPS Health 
Plan Survey 4.0H, 
Adult Version and 
Medicare CAHPS 
(Medicare CAHPS 
collects results for 
only the Advising 
Smokers and 
Tobacco Users to 
Quit rate)
Management of uri-
nary incontinence 
in older adults 
(MUI)
The two components of this measure assess the management of 
urinary incontinence in older adults: 
Discussing urinary incontinence: the percentage of Medicare 
members 65 and older who reported having a problem with 
urine leakage in the past six months and who discussed their 
urine leakage problem with their current practitioner 
Receiving urinary incontinence treatment: the percentage of 
Medicare members 65 and older who reported having a urine 
leakage problem in the past six months and who received treat-
ment for their current urine leakage problem
Survey Documentation may 
be inadequate; treat-
ment may consist of 
medications that can 
promote falls
Effectiveness of 
Care: Measures 
Collected Through 
Medicare Health 
Outcome Survey
NCQA: HEDIS 
2012 Measure 
Set via the 
Medicare Health 
Outcomes Survey
Use of high-risk 
medications in the 
elderly (DAE) 
Percentage of Medicare members 65 and older who received at 
least one high-risk medication 
The percentage of Medicare members 65 and older who 
received at least two different high-risk medications 
(for both rates, a lower rate represents better performance)
Claims 
EHR
There may be valid 
reasons why a patient 
may need to be on 
these medications; 
not much data that 
reducing these 
medications clearly 
improves outcomes—
these criteria are 
controversial
Effectiveness of 
Care: Medication 
Management
NCQA: HEDIS 
2012 Measure 
Set
Source: Commonwealth Fund Patient-Centered Medical Home Evaluators’ Collaborative.
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Appendix A3. Core Recommended Pediatric Technical Quality Measures for PCMH Evaluations
Measure Description
Data  
Source(s)
Composite  
Domain
Measure  
Source
Immunizations for 
adolescents (IMA)
The percentage of adolescents age 13 who had one dose of meningococcal vaccine 
and one tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap) or one 
tetanus, diphtheria toxoids vaccine (Td) by their 13th birthday. The measure calcu-
lates a rate for each vaccine and one combination rate.
Claims 
Medical record
Effectiveness of 
Care: Prevention and 
Screening
NCQA: HEDIS 2012 
Measure Set
Medication 
Management for 
People with Asthma 
(MMA)
The percentage of members ages 5–18 during the measurement year who were 
identified as having persistent asthma and who were dispensed appropriate medi-
cations and remained on their medications during the treatment period. Two rates 
are reported, stratified by ages 5–11 and 12–18: 
1. The percentage of members who remained on an asthma controller medication 
for at least 50% of the treatment period 
2. The percentage of members who remained on an asthma controller medication 
for at least 75% of the treatment period
Claims 
EHR
Effectiveness of 
Care: Respiratory 
Conditions
NCQA: HEDIS 2012 
Measure Set
Adolescent well-
care visits (AWC)
The percentage of enrolled members ages 12–who had at least one comprehensive 
well-care visit with a primary care provider or an OB/GYN practitioner during the 
measurement year
Claims 
Medical record
Utilization and 
Relative Resource 
Use: Utilization
NCQA: HEDIS 2012 
Measure Set
Appropriate testing 
for children with 
pharyngitis (CWP) 
The percentage of children agers 2–18 who were diagnosed with pharyngitis, dis-
pensed an antibiotic and received a group A streptococcus test for the episode 
Claims 
EHR
Effectiveness of 
Care: Respiratory 
Conditions
NCQA: HEDIS 2012 
Measure Set
Childhood immuni-
zation status (CIS)
The percentage of children at age 2 who had four diphtheria, tetanus, and acellular 
pertussis (DTaP); three polio (IPV); one measles, mumps and rubella (MMR); three 
H influenza type B (HiB); three hepatitis B (HepB), one chicken pox (VZV); four 
pneumococcal conjugate (PCV); two hepatitis A (HepA); two or three rotavirus (RV); 
and two influenza vaccines by their second birthday. The measure calculates a rate 
for each vaccine and nine separate combination rates.
Claims 
Medical record 
EHR
Effectiveness of 
Care: Prevention and 
Screening
NCQA: HEDIS 2012 
Measure Set
Chlamydia screen-
ing in women (CHL)
The percentage of women ages 16–24 who were identified as sexually active and 
who had at least one test for chlamydia during the measurement year
Claims 
EHR
Effectiveness of Care: 
Prevention and 
Screening
NCQA: HEDIS 2012 
Measure Set
Follow-up after 
hospitalization 
for mental illness 
(FUH)
The percentage of discharges for members ages 6 and older who were hospitalized 
for treatment of selected mental health disorders and who had an outpatient visit, 
an intensive outpatient encounter, or partial hospitalization with a mental health 
practitioner. Two rates are reported: 
1. The percentage of members who received follow-up within 30 days of discharge 
2. The percentage of members who received follow-up within seven days of 
discharge
Claims Effectiveness of Care: 
Behavioral Health
NCQA: HEDIS 2012 
Measure Set
Follow-up care for 
children prescribed 
attention deficit 
hyperactivity dis-
order medication 
(ADD)
The percentage of children newly prescribed attention-deficit hyperactivity disorder 
(ADHD) medication who had at least three follow-up care visits within a 10-month 
period, one of which was within 30 days of when the first ADHD medication was 
dispensed. Two rates are reported: 
1. Initiation phase: the percentage of members 6–12 as of the index prescription 
start date (IPSD) with an ambulatory prescription dispensed for ADHD medication, 
who had one follow-up visit with practitioner with prescribing authority during the 
30-day Initiation Phase 
2. Continuation and maintenance phase: the percentage of members ages 6–12 as 
of the IPSD with an ambulatory prescription dispensed for ADHD medication, who 
remained on the medication for at least 210 days and who, in addition to the visit 
in the initiation phase, had at least two follow-up visits with a practitioner within 
270 days (9 months) after the initiation phase ended 
Claims 
EHR
Effectiveness of Care: 
Behavioral Health
NCQA: HEDIS 2012 
Measure Set
Weight assessment 
and counseling for 
nutrition and physi-
cal activity for chil-
dren/adolescents 
(WCC)
The percentage of members ages 3–17 who had an outpatient visit with a primary 
care provider or OB/GYN and who had evidence of the following during the mea-
surement year: Body mass index (BMI) percentile documentation; counseling for 
nutrition; counseling for physical activity
Claims 
Medical record 
EHR
Effectiveness of Care: 
Prevention and 
Screening
NCQA: HEDIS 2012 
Measure Set
Well-child visit in 
the first 15 months 
of life (W15)
The percentage of members who turned 15 months old during the measurement 
year and who had the following number of well-child visits with a PCP during their 
first 15 months of life: no well-child visits; one well-child visit; two well-child visits; 
three well-child visits; four well-child visits; five well-child visits; six or more well-
child visits
Claims 
Medical record
Utilization and 
Relative Resource 
Use: Utilization
NCQA: HEDIS 2012 
Measure Set
Well-child visit in 
the third, fourth, 
fifth, and sixth years 
of life (W34)
The percentage of members ages 3–6 who had one or more well-child visits with a 
primary care provider during the measurement year.
Claims 
Medical record
Utilization and 
Relative Resource 
Use: Utilization
NCQA: HEDIS 2012 
Measure Set
Source: Commonwealth Fund Patient-Centered Medical Home Evaluators’ Collaborative.
aBout the authors
Meredith B. Rosenthal, Ph.D., is professor of Health Economics and Policy in the Department of Health Policy 
and Management at the Harvard School of Public Health. Her research examines the design and impact of mar-
ket-based health policy mechanisms, with a particular focus on the use of financial incentives to alter consumer 
and provider behavior. She is currently working on a body of research that examines alternative models for 
reforming physician and hospital payment. Specific empirical projects include evaluations of several patient- 
centered medical home pilots, pay-for-performance initiatives, and an episode-based payment system. Dr. 
Rosenthal received her Ph.D. in health policy from Harvard University.
Melinda K. Abrams, M.S., vice president of The Commonwealth Fund, directs the Fund’s Patient-Centered 
Coordinated Care program. Since coming to the Fund in 1997, Ms. Abrams has worked on the Fund’s Task Force 
on Academic Health Centers, the Commission on Women’s Health, and the Child Development and Preventive 
Care programs. She is a member of the board of managers of TransforMED, the steering committee for the CMS 
Advanced Primary Care Demonstration, the NCQA Patient-Centered Medical Home Advisory Committee, and 
two medical home expert panels for AHRQ. Ms. Abrams has a bachelor’s degree from Cornell University and 
master’s degree in health policy and management from the Harvard School of Public Health.
Asaf Bitton, M.D., M.P.H., is associate physician and instructor in Medicine at the Division of General 
Medicine at Brigham and Women’s Hospital, as well as instructor in Health Care Policy at the Department of 
Health Care Policy at Harvard Medical School. Along with being a practicing primary care physician, his work 
focuses on evaluating the scope and quality improvement possibilities of patient-centered medical home pilots 
locally and nationally, as well ways to effectively transform practices toward new models of primary care. He 
chairs the clinical quality work group in the Commonwealth Fund Patient-Centered Medical Home Evaluators’ 
Collaborative, and also serves as a special advisor to the Center for Medicare and Medicaid Innovation for their 
Comprehensive Primary Care initiative. Dr. Bitton received his M.D. from the University of California, San 
Francisco School of Medicine and his M.P.H. from the Harvard School of Public Health.
Editorial support was provided by Deborah Lorber.
